Home/Filings/4/0001104659-20-010065
4//SEC Filing

Coughlin Christina M. 4

Accession 0001104659-20-010065

CIK 0001709401other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 9:50 PM ET

Size

5.3 KB

Accession

0001104659-20-010065

Insider Transaction Report

Form 4
Period: 2020-01-31
Coughlin Christina M.
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-01-31+375,000375,000 total
    Exercise: $7.80Exp: 2030-01-30Common Stock (375,000 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest on January 6, 2021, then in 12 equal quarterly installments thereafter.

Documents

1 file

Issuer

Rubius Therapeutics, Inc.

CIK 0001709401

Entity typeother

Related Parties

1
  • filerCIK 0001799032

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 9:50 PM ET
Size
5.3 KB